FDA Oversight of Cell Therapy Clinical Trials

被引：28

|

作者：

Au, Patrick ^{[1
]}

Hursh, Deborah A. ^{[1
]}

Lim, Agnes ^{[1
]}

Moos, Malcolm C., Jr. ^{[1
]}

Oh, Steven S. ^{[1
]}

Schneider, Bruce S. ^{[1
]}

Witten, Celia M. ^{[1
]}

机构：

[1] US FDA, Off Cellular Tissue & Gene Therapies, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2012年 / 4卷 / 149期

关键词：

D O I：

10.1126/scitranslmed.3004131

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

收藏

页数：3

相关论文

共 50 条

[1] FDA OVERSIGHT OF CLINICAL TRIALS The US FDA and regulatory free fall
Wilson, Mark
BMJ-BRITISH MEDICAL JOURNAL, 2023, 380
[2] FDA oversight of clinical trials is "grossly inadequate," say experts
Demasi, Maryanne
BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
[3] FDA oversight of clinical trials is "grossly inadequate," say experts
Demasi, Maryanne
BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
[4] Understanding FDA Oversight of Cell Therapies
Smith, Robin L.
GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2012, 32 (20): : 6 - 8
[5] Gene therapy trials oversight
不详
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (15): : 1950 - 1950
[6] Highlights of FDA's Workshop on Gene and Cell Therapy Clinical Trials in Pediatric Populations
不详
HUMAN GENE THERAPY, 2011, 22 (01) : 2 - 2
[7] FDA Expands Oversight of Cell and Gene Therapies
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2022, 35 (11) : 9 - 9
[8] Clarifying Clinical Trials and IACUC Oversight
Kendall, Lon V.
LAB ANIMAL, 2022, 51 (06) : 154 - 154
[9] Clarifying Clinical Trials and IACUC Oversight
Lon V. Kendall
Lab Animal, 2022, 51 : 154 - 154
[10] Stem cell therapy for stroke: preclinical evidence and an update on FDA-approved clinical trials
Borlongan, Cesar V.
NEUROREPORT, 2014, 25 (03) : 140 - 140

← 1 2 3 4 5 →